share_log

維亞生物:完成收購SYNTHESIS MED CHEM (HONG KONG) LIMITED全部股權及當中涉及根據一般授權發行代價股份

Viva Biotech Holdings: COMPLETION OF THE ACQUISITION OF THE ENTIRE EQUITY INTEREST IN SYNTHESIS MED CHEM (HONG KONG) LIMITED INVOLVING ISSUE OF CONSIDERATION SHARES UNDER GENERAL MANDATE

Mar 5, 2021 04:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more